Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sildenafil in Patients With Documented Coronary Vasospasm
NCT00454714Phase 3Withdrawn
- Start
- Mar 2007
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sildenafil in Coronary vasospasm (CAS). Planned start Mar 2007; status: withdrawn.
02
Drugs
sildenafil
03
Conditions
Coronary vasospasm (CAS)
Beyond the preview
Go deeper on NCT00454714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00454714.